Getinge to present additional information at Analyst meeting

Getinge to present additional information at Analyst meeting 

Wayne, 3 February, 2009 

Today, Getinge will hold an Analyst meeting in Wayne, New Jersey, USA, primarily
aimed at providing an update on the Group's increasing presence in the
cardiovascular market. 

Additional information about Getinge's anticipated development will also be
communicated at the meeting, including that sales for 2009 are expected to
amount to approximately SEK 24 billion in the prevailing currency position and
including Datascope. Getinge also announced that during the current year, the
company will likely increase the Group's target for EBITA margin for the period
2010 and onward. As announced earlier, the EBITA margin for the current year is
expected to be in the range of 18 - 19%, which is also the Group's current
target.   

Presentations from the Analyst meeting are available on Getinge's website:
(www.getingegroup.com). 

Getinge AB (publ)
This information is such that Getinge AB is liable to publish in accordance with
the Securities Markets Act and/or the Financial Instruments Trading Act.